These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 12391290)
1. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Kato-Stankiewicz J; Hakimi I; Zhi G; Zhang J; Serebriiskii I; Guo L; Edamatsu H; Koide H; Menon S; Eckl R; Sakamuri S; Lu Y; Chen QZ; Agarwal S; Baumbach WR; Golemis EA; Tamanoi F; Khazak V Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14398-403. PubMed ID: 12391290 [TBL] [Abstract][Full Text] [Related]
2. Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Plattner R; Gupta S; Khosravi-Far R; Sato KY; Perucho M; Der CJ; Stanbridge EJ Oncogene; 1999 Mar; 18(10):1807-17. PubMed ID: 10086335 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors. Skobeleva N; Menon S; Weber L; Golemis EA; Khazak V Mol Cancer Ther; 2007 Mar; 6(3):898-906. PubMed ID: 17363484 [TBL] [Abstract][Full Text] [Related]
4. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Shantz LM; Pegg AE Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886 [TBL] [Abstract][Full Text] [Related]
5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
6. A two-hybrid approach to identify inhibitors of the RAS-RAF interaction. Khazak V; Eyrisch S; Kato J; Tamanoi F; Golemis EA Enzymes; 2013; 33 Pt A():213-48. PubMed ID: 25033807 [TBL] [Abstract][Full Text] [Related]
7. Structural determinants of Ras-Raf interaction analyzed in live cells. Bondeva T; Balla A; Várnai P; Balla T Mol Biol Cell; 2002 Jul; 13(7):2323-33. PubMed ID: 12134072 [TBL] [Abstract][Full Text] [Related]
8. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells. Ulkü AS; Schäfer R; Der CJ Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291 [TBL] [Abstract][Full Text] [Related]
9. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways. Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353 [TBL] [Abstract][Full Text] [Related]
10. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells. Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707 [TBL] [Abstract][Full Text] [Related]
11. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559 [TBL] [Abstract][Full Text] [Related]
12. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E). Karreth FA; DeNicola GM; Winter SP; Tuveson DA Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255 [TBL] [Abstract][Full Text] [Related]
13. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. Rosário M; Paterson HF; Marshall CJ EMBO J; 1999 Mar; 18(5):1270-9. PubMed ID: 10064593 [TBL] [Abstract][Full Text] [Related]
14. Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation. Heinicke T; Radziwill G; Nawrath M; Rommel C; Pavlovic J; Moelling K Cancer Gene Ther; 2000 May; 7(5):697-706. PubMed ID: 10830717 [TBL] [Abstract][Full Text] [Related]
15. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Guha S; Lunn JA; Santiskulvong C; Rozengurt E Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255 [TBL] [Abstract][Full Text] [Related]
16. Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12. Shuman JD; Sebastian T; Kaldis P; Copeland TD; Zhu S; Smart RC; Johnson PF Mol Cell Biol; 2004 Sep; 24(17):7380-91. PubMed ID: 15314150 [TBL] [Abstract][Full Text] [Related]
17. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha. Chang MY; Won SJ; Yang BC; Jan MS; Liu HS Exp Cell Res; 1999 May; 248(2):589-98. PubMed ID: 10222151 [TBL] [Abstract][Full Text] [Related]
18. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1. Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443 [TBL] [Abstract][Full Text] [Related]
19. Calmodulin binds to K-Ras, but not to H- or N-Ras, and modulates its downstream signaling. Villalonga P; López-Alcalá C; Bosch M; Chiloeches A; Rocamora N; Gil J; Marais R; Marshall CJ; Bachs O; Agell N Mol Cell Biol; 2001 Nov; 21(21):7345-54. PubMed ID: 11585916 [TBL] [Abstract][Full Text] [Related]
20. C-Raf is required for the initiation of lung cancer by K-Ras(G12D). Karreth FA; Frese KK; DeNicola GM; Baccarini M; Tuveson DA Cancer Discov; 2011 Jul; 1(2):128-36. PubMed ID: 22043453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]